Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
We might be a step closer to curing HIV, as researchers have developed a way to knock out a version of the virus lurking in the body. Using something called an HIV-like particle (HLP)—which are dead ...
The key obstacle against the cure of human and simian immunodeficiency virus (HIV/SIV) infections is the reservoir of proviruses, which are robustly incorporated into the genomes of host CD4+ T cells.
People with HIV may have to take multiple medicines just to keep the virus under control. Medicines for HIV are usually taken every day, and it is crucial that people do not miss their dose or else ...
Immunocore reports positive initial data for HIV treatment candidate IMC-M113V, showing safety and signs of viral control post-treatment. The observation of delayed viral rebound and/or viremia ...